• 1
    Fritz, J. H., Ferrero, R. L., Philpott, D. J. and Girardin, S. E., Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 2006. 7: 12501257.
  • 2
    Meylan, E., Tschopp, J. and Karin, M., Intracellular pattern recognition receptors in the host response. Nature 2006. 442: 3944.
  • 3
    Werts, C., Girardin, S. E. and Philpott, D. J., TIR, CARD and PYRIN: Three domains for an antimicrobial triad. Cell Death Differ. 2006. 13: 798815.
  • 4
    Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.-P., Belaiche, J., Almer, S. et al., Association of Nod2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001. 411: 599603.
  • 5
    Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H. et al., A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease. Nature 2001. 411: 603606.
  • 6
    Hysi, P., Kabesch, M., Moffatt, M. F., Schedel, M., Carr, D., Zhang, Y., Boardman, B. et al., Nod1 variation, immunoglobulin E, and asthma. Hum. Mol. Genet. 2005. 14: 935941.
  • 7
    McGovern, D. P., Hysi, P., Ahmad, T., van Heel, D. A., Moffatt, M. F., Carey, A., Cookson, W. O. and Jewell, D. P., Association between a complex insertion/deletion polymorphism in Nod1 (CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet. 2005. 14: 12451250.
  • 8
    Tremelling, M., Hancock, L., Bredin, F., Sharpstone, D., Bingham, S. A. and Parkes, M., Complex insertion/deletion polymorphism in Nod1 (CARD4) is not associated with inflammatory bowel disease susceptibility in east anglia panel. Inflamm. Bowel Dis. 2006. 12: 967971.
  • 9
    Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y. et al., An essential role for Nod1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003. 4: 702707.
  • 10
    Girardin, S. E., Boneca, I. G., Carneiro, L. A., Antignac, A., Jehanno, M., Viala, J., Tedin, K. et al., Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003. 300: 15841587.
  • 11
    Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J. and Sansonetti, P. J., Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003. 278: 88698872.
  • 12
    Girardin, S. E., Travassos, L. H., Herve, M., Blanot, D., Boneca, I. G., Philpott, D. J., Sansonetti, P. J. and Mengin-Lecreulx, D., Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 2003. 278: 4170241708.
  • 13
    Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K. et al., Host recognition of bacterial muramyl dipeptide mediated through Nod2. Implications for Crohn's disease. J. Biol. Chem. 2003. 278: 55095512.
  • 14
    Magalhaes, J. G., Philpott, D. J., Nahori, M. A., Jehanno, M., Fritz, J., Bourhis, L. L., Viala, J. et al., Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. 2005. 6: 12011207.
  • 15
    Boughan, P. K., Argent, R. H., Body-Malapel, M., Park, J. H., Ewings, K. E., Bowie, A. G., Ong, S. J. et al., Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: Critical regulators of beta-defensins during Helicobacter pylori infection. J. Biol. Chem. 2006. 281: 1163711648.
  • 16
    Uehara, A., Fujimoto, Y., Kawasaki, A., Kusumoto, S., Fukase, K. and Takada, H., Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through Nod1. J. Immunol. 2006. 177: 17961804.
  • 17
    Voss, E., Wehkamp, J., Wehkamp, K., Stange, E. F., Schroder, J. M. and Harder, J., Nod2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J. Biol. Chem. 2006. 281: 20052011.
  • 18
    Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G. and Flavell, R. A., Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005. 307: 731734.
  • 19
    Masumoto, J., Yang, K., Varambally, S., Hasegawa, M., Tomlins, S. A., Qiu, S., Fujimoto, Y. et al., Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J. Exp. Med. 2006. 203: 203213.
  • 20
    Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004. 25: 677686.
  • 21
    Salazar-Mather, T. P. and Hokeness, K. L., Cytokine and chemokine networks: Pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 2006. 303: 2946.
  • 22
    Decker, T., Muller, M. and Stockinger, S., The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 2005. 5: 675687.
  • 23
    Stockinger, S., Reutterer, B., Schaljo, B., Schellack, C., Brunner, S., Materna, T., Yamamoto, M. et al., IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J. Immunol. 2004. 173: 74167425.
  • 24
    Liu, J. and Ma, X., Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1. J. Biol. Chem. 2006. 281: 1918819195.
  • 25
    Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H. et al., A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 2006. 7: 4048.
  • 26
    Stetson, D. B. and Medzhitov, R., Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006. 24: 93103.
  • 27
    O'Connell, R. M., Vaidya, S. A., Perry, A. K., Saha, S. K., Dempsey, P. W. and Cheng, G., Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. J. Immunol. 2005. 174: 16021607.
  • 28
    Fritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C. et al., Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007. 26: 445459.
  • 29
    Gangemi, J. D., Nachtigal, M., Barnhart, D., Krech, L. and Jani, P., Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus. J. Infect. Dis. 1987. 155: 510517.
  • 30
    Lazdins, J. K., Woods-Cook, K., Walker, M. and Alteri, E., The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophages. AIDS Res. Hum. Retroviruses 1990. 6: 11571161.
  • 31
    Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, R. C., Miller, M., West, M., Ohkawa, S. et al., A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 1989. 246: 12931297.
  • 32
    Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N. and Weis, J. J., Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 2000. 165: 618622.
  • 33
    Liu, J., Guan, X. and Ma, X., Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon γ-induced RANTES/CCL5 expression in macrophages. J. Biol. Chem. 2005. 280: 2434724355.
  • 34
    Ma, X., Chow, J. M., Gri, G., Carra, G., Gerosa, F., Wolf, S. F., Dzialo, R. and Trinchieri, G., The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 1996. 183: 147157.
  • 35
    Ma, X., Neurath, M., Gri, G. and Trinchieri, G., Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem. 1997. 272: 1038910395.